A carregar...

Reprogramming immune response with capsid-optimized AAV6 vectors for immunotherapy of cancer

In the current studies we generated novel capsid-optimized AAV serotype 6 (AAV6) vectors expressing a tumor-associated antigen, and assessed their ability to activate a protective T-cell response in an animal model. First, we showed that specific mutations in the AAV6 capsid increase the transductio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother
Main Authors: Pandya, Munjal, Britt, Kellee, Hoffman, Brad, Ling, Chen, Aslanidi, George V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535186/
https://ncbi.nlm.nih.gov/pubmed/26261893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!